Table 1.
Findings for background components in thyroid lymphoma and Hashimoto thyroiditis with prominent lymphoid proliferation
| MALT-L (35) | DLBCL (3) | HT-PTP (25) | ||
|---|---|---|---|---|
| Colloid material | LBC-S | 22.9% (8) | 0% (0) | 56.0% (14)* |
| C-S | 20.0% (7) | 33.3% (1) | 32.0% (8) | |
| Lymphoglandular bodies | LBC-S | 11.4% (4)††† | 0% (0) | 20.0% (5) |
| C-S | 68.6% (24) | 66.7% (2) | 20.0% (5)*** | |
| Multinucleated giant cells | LBC-S | 14.3% (5) | 0% (0) | 24.0% (6) |
| C-S | 2.9% (1) | 0% (0) | 20.0% (5) | |
| Oxyphilic cell clusters | LBC-S | 42.9% (15) | 0% (0) | 92.0% (23)*** |
| C-S | 20.0% (7) | 0% (0) | 76.0% (19)*** |
MALT-L, mucosa-associated lymphoid tissue lymphoma; DLBCL, diffuse large B-cell cell lymphoma; HT-PTP, Hashimoto thyroiditis with prominent lymphoid proliferation; LBC-S, liquid-based cytology specimens; C-S, conventional specimens.
*
p < 0.05
***
p < 0.001, vs. MALT-L
†††
p < 0.001 vs. C-S.